Literature DB >> 1665152

Interleukin 4 inhibits murine osteoclast formation in vitro.

A Shioi1, S L Teitelbaum, F P Ross, H G Welgus, H Suzuki, J Ohara, D L Lacey.   

Abstract

Interleukin 4 (IL-4) is a product of activated T cells and mast cells with effects on immunologic and hematopoietic processes. We now report that IL-4 inhibits the formation of osteoclasts from murine bone marrow cells cocultured with stromal cells. Numerous (3,000-4,000 cells/2 cm2) tartrate-resistant acid-phosphatase-positive multinucleated cells with the capacity to generate cAMP in response to salmon calcitonin (ED50 = 10(-10) M) developed within 10-12 days of culture. IL-4 (ID50 = 10 U/ml) inhibited osteoclast generation in doses similar to those that induce proliferation of IL-4-responsive T cells. Additionally, the rat antimurine IL-4 monoclonal antibody 11B11 antagonizes the IL-4-inhibitory effect on osteoclast formation. These results suggest that IL-4 impedes agonist-induced in vitro bone resorption by inhibiting osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665152     DOI: 10.1002/jcb.240470313

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  18 in total

Review 1.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

Review 2.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

3.  Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway.

Authors:  M Inaba; Y Nishizawa; A Shioi; H Morii
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Porous bioactive scaffolds: characterization and biological performance in a model of tibial bone defect in rats.

Authors:  Hueliton Wilian Kido; Carla Roberta Tim; Paulo Sérgio Bossini; Nivaldo Antônio Parizotto; Cynthia Aparecida de Castro; Murilo Camuri Crovace; Ana Candida Martins Rodrigues; Edgar Dutra Zanotto; Oscar Peitl Filho; Fernanda de Freitas Anibal; Ana Claudia Muniz Rennó
Journal:  J Mater Sci Mater Med       Date:  2015-01-29       Impact factor: 3.896

Review 5.  Role of cytokines in the regulation of bone resorption.

Authors:  G D Roodman
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

6.  Interleukin 4 enhances osteoblast macrophage colony-stimulating factor, but not interleukin 6, production.

Authors:  D L Lacey; J M Erdmann; M Shima; S Kling; A Matayoshi; J Ohara; S L Perkins
Journal:  Calcif Tissue Int       Date:  1994-07       Impact factor: 4.333

7.  Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.

Authors:  George D Kalliolias; Baohong Zhao; Antigoni Triantafyllopoulou; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  Arthritis Rheum       Date:  2010-02

8.  Interleukin-4 as a bone regulatory factor: effects on murine osteoblast-like cells.

Authors:  J A Riancho; J González-Marcías; J A Amado; J M Olmos; J L Fernández-Luna
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

Review 9.  Osteoimmunology: cytokines and the skeletal system.

Authors:  Seoung-Hoon Lee; Tae-Soo Kim; Yongwon Choi; Joseph Lorenzo
Journal:  BMB Rep       Date:  2008-07-31       Impact factor: 4.778

10.  Osteoporosis induced in mice by overproduction of interleukin 4.

Authors:  D B Lewis; H D Liggitt; E L Effmann; S T Motley; S L Teitelbaum; K J Jepsen; S A Goldstein; J Bonadio; J Carpenter; R M Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.